Belgium
Netherlands

A. Menarini Diagnostics and Sinocare Announce Exclusive Distribution Agreement for New Continuous Glucose Monitoring System

Florence, Italy - 3rd December 2024.  A. Menarini Diagnostics announces an exclusive Distribution Agreement with Sinocare to register, promote, distribute, and market a new Sinocare 3rd Generation Continuous Glucose Monitoring (CGM) System within reimbursed markets. This landmark agreement grants A. Menarini Diagnostics exclusive rights to introduce this health technology to more than 20 jurisdictions in Europe.

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

Florence, Italy, 9 September 2024 - A. Menarini Diagnostics, a company bringing advanced solutions to the in vitro diagnostic market, and Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced at the 36th European Congress of Pathology in Florence, that they have entered into a long-term commercial agreement for the exclusive distribution of the Bladder EpiCheck® test in Europe. 

36th European Congress of Pathology (ECP)

Florence, 7 -11 September 2024

14TH INTERNATIONAL CONGRESS ON AUTOIMMUNITY

Ljubljana, Slovenia, 17 -20 May, 2024

ECCMID 2024

European Congress of Clinical Microbiology and Infectious Diseases

Barcelona, 27 - 30 April 2024

booth D17

12345678

Our Values

4 values, which have given life to Menarini and shaped its history

READ MORE »